NCT00059358View on ClinicalTrials.gov

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
HIV InfectionsHepatitis C
Interventions
DRUG

Ribavirin plus interferon alfa-2b

Oral tablets taken daily

DRUG

Ribavirin

Oral tablet taken daily

DRUG

Peginterferon alfa-2b

Subcutaneous injection

Trial Locations (1)

00936-5067

UPR Adult ACTU, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00059358 - Zidovudine Levels in HIV Infected Patients Being Treated for HCV | Biotech Hunter | Biotech Hunter